Researchers design gene therapy that can effectively target glioblastoma
Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurrent GBM associated with survival of less than 10 months. Immunotherapies, which mobilize the body's immune defenses against ...
Oct 18, 2023
0
344